Thomas W. Beetham insider trades
Open-market stock purchases and sales by Thomas W. Beetham, Chief Operating Officer at Viridian Therapeutics, Inc.\DE, from SEC Form 4 filings since Feb 9, 2018.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $92K |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Sold (not open market) | $92K |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Bought (not open market) | — |